Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Anemia | Research article

Glutathione, glutathione peroxidase and some hematological parameters of HIV-seropositive subjects attending clinic in University of Calabar teaching hospital, Calabar, Nigeria

Authors: Stephen Bassey Coco-Bassey, Enosakhare A. Asemota, Henshaw Uchechi Okoroiwu, Joyce E. Etura, Esienanwan Esien Efiong, Imeobong J. Inyang, Emmanuel K. Uko

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Despite the numerous intervention programmes, HIV still remains a public health concern with a high impact in Sub-Saharan Africa region. Oxidative stress has been documented in HIV subjects as viral infection promotes prolonged activation of immune system, hence, production of increased reactive oxygen species.

Methods

We studied 180 subjects. Of these, 60 were HIV-infected on antiretroviral therapy (ART), 40 were ART naïve HIV-infected and 80 were apparent healthy non HIV-infected subjects. The complete blood count was performed by automated hemoanalyzer, the CD4+ T-cell count was performed by cyflow cytometer, while the antioxidant assay was performed using ELISA technique.

Result

All evaluated parameters; glutathione (GSH), glutathione peroxidase (GPX), CD4+ T-cell count, haemoglobin (Hb), total white blood cell count (WBC) and platelet count were significantly (P < 0.05) reduced in the HIV-infected subjects. All assessed parameters were found to be significantly (P < 0.5) reduced in the HIV-infected subjects that are ART naive when compared with those on ART. HIV-infected subjects with CD4+ T-cell count < 200 cells/mm3 had significantly (P < 0.05) reduced values in all assessed parameters when compared to those with CD4+ T-cell count ≥200 cells/mm3. GSH and WBC were found to be significantly (P < 0.05) increased in the female HIV-infected subjects when compared with the male counterpart. Anemia prevalence of 74 and 33% were recorded for the HIV-infected and control subjects, respectively. Gender and ART treatment were found to be associated with anemia in HIV. Male HIV-infected subjects on ART were found to be more likely to have anemia.

Conclusion

Antioxidants; GSH and GPX were found to be significantly reduced in HIV infection. Further probe showed that the antioxidant status was improved in the HIV-infected group on ART.
Literature
2.
go back to reference Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health. 2018;18:645. Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health. 2018;18:645.
3.
go back to reference Obiomah CF, Obeagu EI, Ochei KC, Swem CA, Amachukwu BO. Hematological indices o HIV seropositive subjects in Nnamdi Azikiwe University teaching hospital (NAUTH), Nnewi. Ann Clin Lab Res. 2018;6(1):1–4. Obiomah CF, Obeagu EI, Ochei KC, Swem CA, Amachukwu BO. Hematological indices o HIV seropositive subjects in Nnamdi Azikiwe University teaching hospital (NAUTH), Nnewi. Ann Clin Lab Res. 2018;6(1):1–4.
4.
go back to reference Nsonwu-Anyanwu AC, Ighodalo EV, King D, Agu CE, Jeremiah S, Solomon OT, Usoro CAO. Biomarkers of oxidative stress in HIV seropositive individuals on highly active antiretroviral therapy. React Oxygen Species. 2017;3(9):1–11. Nsonwu-Anyanwu AC, Ighodalo EV, King D, Agu CE, Jeremiah S, Solomon OT, Usoro CAO. Biomarkers of oxidative stress in HIV seropositive individuals on highly active antiretroviral therapy. React Oxygen Species. 2017;3(9):1–11.
5.
go back to reference Joint United Nations Programme on HIV and AIDS (UNAIDS). The gap report: Children and pregnant women living with HIV. Geneva: UNAIDS; 2014. Joint United Nations Programme on HIV and AIDS (UNAIDS). The gap report: Children and pregnant women living with HIV. Geneva: UNAIDS; 2014.
8.
go back to reference Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Res. 2018;25(4):697–703.CrossRef Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Res. 2018;25(4):697–703.CrossRef
9.
go back to reference Federal Ministry of Health. National guidelines for HIV prevention, treatment and care. National AIDS and STIs control Programme. Abuja: Federal Ministry of Health; 2016. Pp 1–218. Federal Ministry of Health. National guidelines for HIV prevention, treatment and care. National AIDS and STIs control Programme. Abuja: Federal Ministry of Health; 2016. Pp 1–218.
10.
go back to reference Watanabe LM, Barbosa F, Jordao AA, Navarro AM. Influence of HIV infection and the use of antiretroviral therapy on selenium and selenomethionine concentrations and antioxidants protection. Nutrition. 2016;32(1):38–1242. Watanabe LM, Barbosa F, Jordao AA, Navarro AM. Influence of HIV infection and the use of antiretroviral therapy on selenium and selenomethionine concentrations and antioxidants protection. Nutrition. 2016;32(1):38–1242.
12.
go back to reference Zhao L, Cox AG, Ruzicka JA, Bhat AA, Zhang W, Taylor EW. Molecular modeling and in vitro activity of HIV-1-encoded glutathione peroxidase. Proc Natl Acad. 2000;97:6356–61.CrossRef Zhao L, Cox AG, Ruzicka JA, Bhat AA, Zhang W, Taylor EW. Molecular modeling and in vitro activity of HIV-1-encoded glutathione peroxidase. Proc Natl Acad. 2000;97:6356–61.CrossRef
13.
go back to reference Stephensen CB, Marquis GS, Douglas SD, Wilson CM. Immune activation and oxidation damage in HIV-positive and HIV-negative adolescents. J Acquir Immune Defic Syndr. 2005;38:180–90.PubMedCrossRef Stephensen CB, Marquis GS, Douglas SD, Wilson CM. Immune activation and oxidation damage in HIV-positive and HIV-negative adolescents. J Acquir Immune Defic Syndr. 2005;38:180–90.PubMedCrossRef
14.
go back to reference Steinbrenner H, Al-Quraishy S, Dkhil MA, Wunderlich F, Helmut S. Dietary selenium in adjuvant therapy of viral and bacterial infections. Adv Nutr. 2015;6:73–82.PubMedPubMedCentralCrossRef Steinbrenner H, Al-Quraishy S, Dkhil MA, Wunderlich F, Helmut S. Dietary selenium in adjuvant therapy of viral and bacterial infections. Adv Nutr. 2015;6:73–82.PubMedPubMedCentralCrossRef
15.
go back to reference Aukrust P, Miller F, Svardal AM, Ueland T, Berge RK, Freland SS. Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active retroviral therapy-potential immunomodulatory effects of antioxidants. J Infect Dis. 2003;188:232–8.PubMedCrossRef Aukrust P, Miller F, Svardal AM, Ueland T, Berge RK, Freland SS. Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active retroviral therapy-potential immunomodulatory effects of antioxidants. J Infect Dis. 2003;188:232–8.PubMedCrossRef
16.
go back to reference Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res. 1999;31:261–72.PubMedCrossRef Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res. 1999;31:261–72.PubMedCrossRef
17.
go back to reference Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling and cell injury. Free Radic Biol Med. 2000;28:1456–62.PubMedCrossRef Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling and cell injury. Free Radic Biol Med. 2000;28:1456–62.PubMedCrossRef
18.
go back to reference Orem A, Yandi Y, Vanizor B, Cimsit G, Uydu HA, Malkoc M. The evaluation of the autoantibodies against oxidatively modified low density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxidase levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behcet’s disease. Clin Biochem. 2002;35:217–24.PubMedCrossRef Orem A, Yandi Y, Vanizor B, Cimsit G, Uydu HA, Malkoc M. The evaluation of the autoantibodies against oxidatively modified low density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxidase levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behcet’s disease. Clin Biochem. 2002;35:217–24.PubMedCrossRef
19.
go back to reference Sundaram M, Saghayam S, Priya B, Venkatesh KK, Balakrishnan P, Shankar EM, et al. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India. I J Infect Dis. 2008;12:e61–6. Sundaram M, Saghayam S, Priya B, Venkatesh KK, Balakrishnan P, Shankar EM, et al. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India. I J Infect Dis. 2008;12:e61–6.
20.
go back to reference Cribs SK, Guidof DM, Martin GS, Lenox J, Brown LA. Anti-retroviral therapy is associated with decreased alveolar glutathione levels even in healthy HIV-infected individuals. PLoS One. 2014;9(2):e88630.CrossRef Cribs SK, Guidof DM, Martin GS, Lenox J, Brown LA. Anti-retroviral therapy is associated with decreased alveolar glutathione levels even in healthy HIV-infected individuals. PLoS One. 2014;9(2):e88630.CrossRef
21.
go back to reference Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A. 1997;9:1967–72.CrossRef Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A. 1997;9:1967–72.CrossRef
22.
go back to reference Saing T, Lagman M, Castrillion J, Gitierrez E, Guilford F, Venketaraman V. Analysis of glutathione level in the brain tissue samples from HIV-1 positive individuals and subjects with Alzheimer’s disease and its implication in the pathophysiology of the disease processes. BBA Clin. 2016;6:38–44.PubMedPubMedCentralCrossRef Saing T, Lagman M, Castrillion J, Gitierrez E, Guilford F, Venketaraman V. Analysis of glutathione level in the brain tissue samples from HIV-1 positive individuals and subjects with Alzheimer’s disease and its implication in the pathophysiology of the disease processes. BBA Clin. 2016;6:38–44.PubMedPubMedCentralCrossRef
23.
go back to reference Staal FJ. Glutathione and HIV-1 infection: reduced or increased oxidized. Eur J Clin Investig. 1998;28(3):194–6.CrossRef Staal FJ. Glutathione and HIV-1 infection: reduced or increased oxidized. Eur J Clin Investig. 1998;28(3):194–6.CrossRef
25.
go back to reference Jahoor F, Jackson A, Gazzard B, Philips G, Sharpstone D, Frazer ME, et al. Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate. Am J Physiol Endocrinol Metab. 1999;276:E205–11.CrossRef Jahoor F, Jackson A, Gazzard B, Philips G, Sharpstone D, Frazer ME, et al. Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate. Am J Physiol Endocrinol Metab. 1999;276:E205–11.CrossRef
26.
go back to reference de Quay B, Malinverni R, Lauterburg BH. Glutathione depletion in HIV-infected patients: role of cystein deficiency and effect of oral N-acetylcystein. AIDS. 1992;6:815–9.PubMedCrossRef de Quay B, Malinverni R, Lauterburg BH. Glutathione depletion in HIV-infected patients: role of cystein deficiency and effect of oral N-acetylcystein. AIDS. 1992;6:815–9.PubMedCrossRef
27.
go back to reference Borges-Santos MD, Moreto F, Pereira CM, Ming-Yu Y, Burini RC. Plasma glutathione of HIV patients responded positively and differently to dietary supplementation with cysteine or glutamine. Nutrition. 2012;28:753–6.PubMedCrossRef Borges-Santos MD, Moreto F, Pereira CM, Ming-Yu Y, Burini RC. Plasma glutathione of HIV patients responded positively and differently to dietary supplementation with cysteine or glutamine. Nutrition. 2012;28:753–6.PubMedCrossRef
30.
go back to reference Moris D, Ly J, Chi P, Daliva J, Nguyen T, Soofer C, et al. Glutathione synthetic is compromised in erythrocytes from individuals with HIV. Front Pharmacol. 2014;5:1–6. Moris D, Ly J, Chi P, Daliva J, Nguyen T, Soofer C, et al. Glutathione synthetic is compromised in erythrocytes from individuals with HIV. Front Pharmacol. 2014;5:1–6.
31.
go back to reference Ehret A, Westendorp MO, Herr I, Debatin KM, Heeny JL, Frank R, et al. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 tat-enhanced oxidative stress and apoptosis. J Virol. 1996;70:6502–7.PubMedPubMedCentral Ehret A, Westendorp MO, Herr I, Debatin KM, Heeny JL, Frank R, et al. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 tat-enhanced oxidative stress and apoptosis. J Virol. 1996;70:6502–7.PubMedPubMedCentral
32.
go back to reference Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, McCord JM. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in Hela cells. Proc Natl Acad Sci U S A. 1993;90(16):7632–6.PubMedPubMedCentralCrossRef Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, McCord JM. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in Hela cells. Proc Natl Acad Sci U S A. 1993;90(16):7632–6.PubMedPubMedCentralCrossRef
33.
go back to reference Flores S, McCord J. Oxyradicals in medical biology: in advances in molecular and cell biology. Bittar EE, McCord J. (eds). Vol 25. London: JAI Press Inc; 1998. Flores S, McCord J. Oxyradicals in medical biology: in advances in molecular and cell biology. Bittar EE, McCord J. (eds). Vol 25. London: JAI Press Inc; 1998.
34.
go back to reference Choi J, Liu RM, Kundu RK, Sangiorgi F, Wu W, Maxson R, et al. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 tat-transgenic mice. J Biol Chem. 2000;275:3693–8.PubMedCrossRef Choi J, Liu RM, Kundu RK, Sangiorgi F, Wu W, Maxson R, et al. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 tat-transgenic mice. J Biol Chem. 2000;275:3693–8.PubMedCrossRef
35.
go back to reference McCarty MF, O'Keefe JH, DiNicolantonio JJ. Dietary Glycine is rate-limiting for glutathione synthesis and may have broad potential for health protection. Ochsner J. 2018;18(1):81–7.PubMedPubMedCentral McCarty MF, O'Keefe JH, DiNicolantonio JJ. Dietary Glycine is rate-limiting for glutathione synthesis and may have broad potential for health protection. Ochsner J. 2018;18(1):81–7.PubMedPubMedCentral
36.
go back to reference Trotti R, Rondanelli M, Anesi A, Gabanti E, Brustia R, Minoli L. Increased erythrocyte glutathione peroxidase activity and serum tumor necrosis factor-α in HIV-infected patients: relationship to on-going prothrombotic state. J Hemother Stem Cell Res. 2002;11(2):369–75.CrossRef Trotti R, Rondanelli M, Anesi A, Gabanti E, Brustia R, Minoli L. Increased erythrocyte glutathione peroxidase activity and serum tumor necrosis factor-α in HIV-infected patients: relationship to on-going prothrombotic state. J Hemother Stem Cell Res. 2002;11(2):369–75.CrossRef
37.
go back to reference Pasupathi PP, Ramachandran T, Sindhu PJ, Saravanan G. Bakthavathsalam. Enhanced oxidative stress markers and antioxidant imbalance in HIV infection and AIDS patients. J Sci Res. 2009;1(2):370–80.CrossRef Pasupathi PP, Ramachandran T, Sindhu PJ, Saravanan G. Bakthavathsalam. Enhanced oxidative stress markers and antioxidant imbalance in HIV infection and AIDS patients. J Sci Res. 2009;1(2):370–80.CrossRef
38.
go back to reference Delmas-Beauvieux M, Peuchant E, Couchouron A, Constans J, Sergeant C, Simonoff M, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or β-carotene. Am J Clin Nutr. 1996;64:101–7.PubMedCrossRef Delmas-Beauvieux M, Peuchant E, Couchouron A, Constans J, Sergeant C, Simonoff M, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or β-carotene. Am J Clin Nutr. 1996;64:101–7.PubMedCrossRef
39.
go back to reference Banos G, Medina-Campos ON, Maldonado PD, Zamora J, Perez I, Pavon N, et al. Antioxidant enzymes in hytertensive and hypertriglyceridemic rat: effects of gender. Clin Exp Hypertens. 2005;27:45–57.PubMedCrossRef Banos G, Medina-Campos ON, Maldonado PD, Zamora J, Perez I, Pavon N, et al. Antioxidant enzymes in hytertensive and hypertriglyceridemic rat: effects of gender. Clin Exp Hypertens. 2005;27:45–57.PubMedCrossRef
40.
go back to reference Barp J, Araujo AS, Fernandes TR, Rigatto KV, Llesuy S, Bello-Klein A, et al. Myocardial antioxidant and oxidative stress change due to sex hormones. Braz J Med Biol Res. 2002;35(9):1075–81.PubMedCrossRef Barp J, Araujo AS, Fernandes TR, Rigatto KV, Llesuy S, Bello-Klein A, et al. Myocardial antioxidant and oxidative stress change due to sex hormones. Braz J Med Biol Res. 2002;35(9):1075–81.PubMedCrossRef
41.
go back to reference Katalinic V, Modun D, Music I, Boban M. Gender differences in antioxidant capacity of rat tissues determined by 2,2’ – azinobis (3-ethyl-benzothiazoline 6-sulfate ; ABIS) and ferric reducing antioxidant power (FRAP) assays. Comp Biochem Physiol C Toxicol Pharmacol. 2005;140:47–52.PubMedCrossRef Katalinic V, Modun D, Music I, Boban M. Gender differences in antioxidant capacity of rat tissues determined by 2,2 – azinobis (3-ethyl-benzothiazoline 6-sulfate ; ABIS) and ferric reducing antioxidant power (FRAP) assays. Comp Biochem Physiol C Toxicol Pharmacol. 2005;140:47–52.PubMedCrossRef
42.
go back to reference Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallador FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med. 2003;34:546–52.PubMedCrossRef Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallador FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med. 2003;34:546–52.PubMedCrossRef
43.
go back to reference Jang YM, Kendaiah S, Drew B, Philips T, Selma C, Julian D, Leeuwenburg C. Doxorubicin treatment in vivo activates capase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett. 2004;577:483–90.PubMedCrossRef Jang YM, Kendaiah S, Drew B, Philips T, Selma C, Julian D, Leeuwenburg C. Doxorubicin treatment in vivo activates capase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett. 2004;577:483–90.PubMedCrossRef
44.
go back to reference Asemota EA, Okafor IM, Okoroiwu HU, Ekong ER, Anyanwu SO, Efiong EE, et al. Zinc, copper, CD4 T-cell count and some hematological parameters of HIV infected subjects in southern Nigeria. Integr Med Res. 2018;7(1):53–60.PubMedPubMedCentralCrossRef Asemota EA, Okafor IM, Okoroiwu HU, Ekong ER, Anyanwu SO, Efiong EE, et al. Zinc, copper, CD4 T-cell count and some hematological parameters of HIV infected subjects in southern Nigeria. Integr Med Res. 2018;7(1):53–60.PubMedPubMedCentralCrossRef
45.
go back to reference Nsonwu-Ayanwu AC, Egbe ER, Agu CE, Offor SJ, Usoro CA, Essien IA, et al. Nutritional indices and cardiovascular risk factors in HIV infections in southern Nigeria. J Immunol Microbiol. 2017;2:34–42. Nsonwu-Ayanwu AC, Egbe ER, Agu CE, Offor SJ, Usoro CA, Essien IA, et al. Nutritional indices and cardiovascular risk factors in HIV infections in southern Nigeria. J Immunol Microbiol. 2017;2:34–42.
46.
go back to reference Valdivia A, Ly J, Gonzalez L, Hussain P, Saing T, Islamoglu H, et al. Restoring cytokine balance in HIV-positive individuals with low CD4 T-cell count. AIDS Res Hum Retrovir. 2017;33(9):905–18.PubMedCrossRefPubMedCentral Valdivia A, Ly J, Gonzalez L, Hussain P, Saing T, Islamoglu H, et al. Restoring cytokine balance in HIV-positive individuals with low CD4 T-cell count. AIDS Res Hum Retrovir. 2017;33(9):905–18.PubMedCrossRefPubMedCentral
47.
go back to reference Okoroiwu HU, Okafor IM, Uko EK, Atangwho IJ. Some hematological parameters of wistar rats treated with chromolaena odorata leave extracts. J Biol Res. 2017;90:51–5.CrossRef Okoroiwu HU, Okafor IM, Uko EK, Atangwho IJ. Some hematological parameters of wistar rats treated with chromolaena odorata leave extracts. J Biol Res. 2017;90:51–5.CrossRef
48.
go back to reference Ositadinma IM, Odozi EB, Meludu SC, Okeke CO. Effects of HIV infection on some hematological parameter and immunoglobulin levels in HIV patients in Benin City, Nigeria, Tanzan. J Health Res. 2009;11:1–4. Ositadinma IM, Odozi EB, Meludu SC, Okeke CO. Effects of HIV infection on some hematological parameter and immunoglobulin levels in HIV patients in Benin City, Nigeria, Tanzan. J Health Res. 2009;11:1–4.
49.
go back to reference Erhabor O, Ejele OA, Nwauche CA, Buseri FI. Some hematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective. Niger J Med. 2005;14:33–8.PubMed Erhabor O, Ejele OA, Nwauche CA, Buseri FI. Some hematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective. Niger J Med. 2005;14:33–8.PubMed
50.
go back to reference Omoregie R, Omokaro EU, Palmer O, Ogefere HO, Egbeobauwaye A, Adegue JE, et al. Prevalence of anemia among HIV-infected patients in Benin City, Nigeria Tanzan. J Health Res. 2009;11:1–4. Omoregie R, Omokaro EU, Palmer O, Ogefere HO, Egbeobauwaye A, Adegue JE, et al. Prevalence of anemia among HIV-infected patients in Benin City, Nigeria Tanzan. J Health Res. 2009;11:1–4.
51.
go back to reference Pennap GR, Abubakar K. Prevalence of anemia among human immunodeficiency virus infected patients accessing healthcare in Federal Medical Centre Keffi, Nigeria. Int J Tro Dis Health. 2015;10:1–7.CrossRef Pennap GR, Abubakar K. Prevalence of anemia among human immunodeficiency virus infected patients accessing healthcare in Federal Medical Centre Keffi, Nigeria. Int J Tro Dis Health. 2015;10:1–7.CrossRef
52.
go back to reference Creagh T, Mildvan D. Greater prevalence of anemia in women and African Americans with HIV/AIDS in HAART era: a study of 10,000 patients (abstract 475). In: The anemia prevalence study group, programme and abstracts of the 40th annual meeting of the Infections Disease Society of America (Chicago), vol. 127. Alexandria: VA Infections Disease Society of America; 2002. Creagh T, Mildvan D. Greater prevalence of anemia in women and African Americans with HIV/AIDS in HAART era: a study of 10,000 patients (abstract 475). In: The anemia prevalence study group, programme and abstracts of the 40th annual meeting of the Infections Disease Society of America (Chicago), vol. 127. Alexandria: VA Infections Disease Society of America; 2002.
53.
go back to reference Levine AM, Berhane K, Masri-Lavine L, et al. Prevalence and correlate of anemia in a large cohort of HIV infected women: Women’s interagency of HIV study. J Aquir Immune Defic Syndr. 2001;26:28–35.CrossRef Levine AM, Berhane K, Masri-Lavine L, et al. Prevalence and correlate of anemia in a large cohort of HIV infected women: Women’s interagency of HIV study. J Aquir Immune Defic Syndr. 2001;26:28–35.CrossRef
54.
go back to reference Semba RD, Shah N, Klein RS, et al. Prevalence and cumulative incidence of and risk factors for anemia in a multicentre cohort study of immunodeficiency virus-infected and uninfected women. Clin Infect Dis. 2002;34:260–6.PubMedCrossRef Semba RD, Shah N, Klein RS, et al. Prevalence and cumulative incidence of and risk factors for anemia in a multicentre cohort study of immunodeficiency virus-infected and uninfected women. Clin Infect Dis. 2002;34:260–6.PubMedCrossRef
55.
go back to reference Voilberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;30(10):1454–63.CrossRef Voilberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;30(10):1454–63.CrossRef
56.
go back to reference Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with Zidovudin. N Engl J Med. 1990;322:1488–93.PubMedCrossRef Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with Zidovudin. N Engl J Med. 1990;322:1488–93.PubMedCrossRef
57.
go back to reference Walker RE, Parker RI, Kovacs JA, et al. Anemia and erythropoiesis and patients with acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudin. Ann Intern Med. 1988;108:372–6.PubMedCrossRef Walker RE, Parker RI, Kovacs JA, et al. Anemia and erythropoiesis and patients with acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudin. Ann Intern Med. 1988;108:372–6.PubMedCrossRef
58.
go back to reference Falguera M, Perez-Mur J, Puig T, Cao G. Study of the role of vitamin B12 and folinic supplementation in preventing hematologic toxicity of zidovudin. Eur J Haematol. 1995;55:97–102.PubMedCrossRef Falguera M, Perez-Mur J, Puig T, Cao G. Study of the role of vitamin B12 and folinic supplementation in preventing hematologic toxicity of zidovudin. Eur J Haematol. 1995;55:97–102.PubMedCrossRef
59.
go back to reference Chen SC, Yu JK, Harries AD, et al. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Tropical Med Int Health. 2008;13:513–9.CrossRef Chen SC, Yu JK, Harries AD, et al. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Tropical Med Int Health. 2008;13:513–9.CrossRef
60.
go back to reference Taylor-Smith K, Tweya H, Harries A, Schoutene E, Jahn A. Gender difference in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Med J. 2010;22(2):49–56.PubMedPubMedCentralCrossRef Taylor-Smith K, Tweya H, Harries A, Schoutene E, Jahn A. Gender difference in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Med J. 2010;22(2):49–56.PubMedPubMedCentralCrossRef
61.
go back to reference De Rossa SC, Zaretsky MD, Dubs JG, Roedera M, Anderson M, Green A. N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Investig. 2000;30(10):915–25.CrossRef De Rossa SC, Zaretsky MD, Dubs JG, Roedera M, Anderson M, Green A. N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Investig. 2000;30(10):915–25.CrossRef
62.
go back to reference Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-acetylcysteine – a safe antidote for cysteine/ glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355–9.PubMedPubMedCentralCrossRef Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-acetylcysteine – a safe antidote for cysteine/ glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355–9.PubMedPubMedCentralCrossRef
Metadata
Title
Glutathione, glutathione peroxidase and some hematological parameters of HIV-seropositive subjects attending clinic in University of Calabar teaching hospital, Calabar, Nigeria
Authors
Stephen Bassey Coco-Bassey
Enosakhare A. Asemota
Henshaw Uchechi Okoroiwu
Joyce E. Etura
Esienanwan Esien Efiong
Imeobong J. Inyang
Emmanuel K. Uko
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4562-6

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.